CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma...
Phase 3
Tampa, Florida, United States and 86 other locations
The purpose of this study is to determine if neoadjuvant (treatment before surgery) immunotherapy treatment based on tumor biomarkers results in bett...
Phase 2
Tampa, Florida, United States
manner the recurrence-free survival (RFS) of Stage IIIB/C/D melanoma patients with respect to the standard of care (surgery and adjuvant the...
Phase 3
Tampa, Florida, United States and 36 other locations
receiving a lymphodepleting chemotherapy regimen and before receiving interleukin-2 (IL-2) in participants with unresectable or metastatic melanoma...
Phase 1
Tampa, Florida, United States
The goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma....
Phase 2
Tampa, Florida, United States
The primary aim of the study is to establish the maximum-tolerated dose (MTD) of 225Ac-MTI-201 in participants with metastatic uveal melanoma...
Phase 1
Tampa, Florida, United States
vemurafenib plus cobimetinib in participants with BRAF V600 mutated melanoma and to evaluate the safety and tolerability of this combination....
Phase 1
Tampa, Florida, United States
The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...
Phase 3
Tampa, Florida, United States and 107 other locations
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Tampa, Florida, United States and 72 other locations
sub-type 1 receptor (MC1R) is being evaluated as a monotherapy and in combination with nivolumab in subjects with unresectable and metastatic melanoma...
Phase 1, Phase 2
Sarasota, Florida, United States of America and 14 other locations
Clinical trials
Research sites
Resources
Legal